Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity

Endocrinology. 1981 Apr;108(4):1597-9. doi: 10.1210/endo-108-4-1597.

Abstract

Kinetic evidence is presented for a time-dependent decrease in human placental aromatase activity by enzyme-generated intermediates derived from two widely used steroids previously described as competitive inhibitors of estrogen biosynthesis. Thus, 4-androstene-3,6,17-trione binds to the enzyme with an apparent Ki of 0.43 microM and has a pseudo-first order overall rate constant for decrease in activity of 4.03x10(-3)sec-1, while 1,4,6-androstatriene-3,17-dione has an apparent Ki of 0.18 microM and a pseudo-first order overall rate constant for decrease in activity of 1.10x10(-3)sec-1. These findings imply that the potent inhibition of estrogen biosynthesis caused by these steroids results primarily from a decrease in enzyme activity caused by enzyme-generated intermediates from the parent steroids.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstatrienes / metabolism*
  • Androstatrienes / pharmacology
  • Androstenes / metabolism*
  • Androstenes / pharmacology
  • Aromatase / metabolism*
  • Female
  • Humans
  • Kinetics
  • Microsomes / enzymology*
  • Oxidoreductases / metabolism*
  • Placenta / enzymology*
  • Pregnancy

Substances

  • Androstatrienes
  • Androstenes
  • androsta-1,4,6-triene-3,17-dione
  • Oxidoreductases
  • Aromatase
  • androst-4-ene-3,6,17-trione